Current concepts on intrathecal humoral immune response and diagnostic importance of oligoclonal immunoglobulins in multiple sclerosis

Makshakov G.S.; Lapin S.V.; Evdoshenko E.P.

doi:https://doi.org/10.17116/jnevro20161162214-20

Close metadata

Recommended articles:

Cognitive impairment in patients with multiple sclerosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):67-73

Molecular mechanisms of acute disseminated encephalomyelitis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7-2):7-11

The role of monocytes in the immunopathogenesis of multiple sclerosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7-2):23-27

Results of a 5-year project for the early diagnosis of multiple sclerosis in first-line blood relatives (RADIRS program). S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7-2):28-33

Current epidemiology of MS with onset in childhood and adolescence (pediatric multiple sclerosis). S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7-2):34-38

Hormonal contraception methods and multiple sclerosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):24-30

Epidemiology of multiple sclerosis in the city of Novosibirsk. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):119-127

Comparing the efficacy of divozilimab and second-line treatments for relapsing-remitting multiple sclerosis in the Russian Federation: a systematic review and network meta-analysis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(2):58-68

A clinical case of X-linked adrenoleukodystrophy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4):102-107

Artificial intelligence capabilities in multiple sclerosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):14-21

Abstract:

Multiple sclerosis (MS) is a demyelinating disease of the central nervous system of probable autoimmune origin. In this review of literature, the authors present a constantly broadening list of potential antigens, including myelin and non-myelin structures, that cause the autoimmune reaction. Determination of antibodies to any antigen has not sufficient specificity and sensitivity for the use in routine laboratory practice. Oligoclonal immunoglobulins determined with isoelectric focusing (IEF) technique are currently considered as the main immunological MS markers. The sensitivity and specificity of IEF are 90 and 86%, respectively. The authors have considered the additional markers such as oligoclonal IgM and MRZ-response.

Keywords:

multiple sclerosis

oligoclonal immunoglobulins

isoelectric focusing

MRZ-response

oligoclonal immunoglobulin M

Authors:

Makshakov G.S.

Tsentr rassejannogo skleroza i drugih demielinizirujuschih zabolevaniĭ Gorodskoĭ klinicheskoĭ bolnitsy №31, Sankt-Peterburg

Lapin S.V.

Pavlov First St. Petersburg State Medical University, Russia, 197022, St. Petersburg, St. Leo Tolstoy 6/8

ORCID: 0000-0002-4998-3699

Evdoshenko E.P.

Sankt-Peterburgskoe GBUZ "Gorodskaia klinicheskaia bol'nitsa #31", Sankt-Peterburgskiĭ gorodskoĭ Tsentr rasseiannogo skleroza i autoimmunnykh zabolevaniĭ, Sankt-Peterburg

Scopus AuthorID: 51763507000
ORCID: 0000-0002-8006-237X

Close metadata

References:

Lucchinetti CF, Hohlfeld R. Multiple Sclerosis three. IV. Series: Blue books of neurology; 35. Saunders. 2010;6:122-124.
Boiko A.N., Smirnova N.F., Zolotova S.N., Gusev E.I. Epidemiologiya i etiologiya rasseyannogo skleroza. Consilium Medicum. 2008;10:7:5-8.
Freedman M, Thompson E, Deisenhammer F et al. Recommended Standard of Cerebrospinal Fluid Analysis in the Diagnosis of Multiple Sclerosis. Arch Neurol. 2005;62(6). doi:10.1001/archneur.62.6.865.
Lapin C.V., Evdoshenko E.P. Laboratornye metody diagnostiki rasseyannogo skleroza i drugikh nevrologicheskikh zabolevanii. Spravochnik zaveduyushchego KDL. 2011;1:22-32.
Meinl E, Krumbholz M, Hohlfeld R. B lineage cells in the inflammatory central nervous system environment: Migration, maintenance, local antibody production, and therapeutic modulation. Annals of Neurology. 2006;59(6):880-892. doi:10.1002/ana.20890.
Serafini B, Rosicarelli B, Magliozzi R, Stigliano E, Aloisi F. Detection of Ectopic B-cell Follicles with Germinal Centers in the Meninges of Patients with Secondary Progressive Multiple Sclerosis. Brain Pathology. 2004;14(2):164-174. doi:10.1111/j.1750-3639.2004.tb00049.x.
Owens G, Bennett J, Gilden D, Burgoon M. The B cell response in multiple sclerosis. Neurological Research. 2006;28(3):236-244. doi:10.1179/016164106x98099.
Chekhonin V.P., Semenova A.V., Turina O.I., Dmitrieva T.B. Mielin-oligodendrotsitarnyi glikoprotein: stroenie, funktsii, rol' v patogeneze demieliniziruyushchikh zabolevanii. Biomeditsinskaya khimiya. 2003;49:5:411-423.
Demina T.V., Davydovskaya M.V., Khachanova N.V., Popova N.F., Gusev E.I. Rasseyannyi skleroz: patogenez, diagnostika, differentsial'nyi diagnoz i lechenie. Nevrologiya i revmatologiya. Prilozhenie k zhurnalu ConsiliumMedicum. 2008;1:84-90.
Owens G, Bennett J, Lassmann H, O’Connor K, Ritchie A, Shearer A, Lam C, Yu X, Birlea M, DuPree C, Williamson R, Hafler D, Burgoon M, Gilden D. Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid. Annals of Neurology. 2009;65(6):639-649. doi: 10.1002/ana.21641.
Menge T, Lalive P, von Büdingen H, Genain C. Conformational epitopes of myelin oligodendrocyte glycoprotein are targets of potentially pathogenic antibody responses in multiple sclerosis. Journal of Neuroinflammation. 2011;8(1):161. doi:10.1186/1742-2094-8-161.
Menge T, von Büdingen H, Lalive P, Genain C. Relevant antibody subsets against MOG recognize conformational epitopes exclusively exposed in solid-phase ELISA. European Journal of Immunology. 2007;37(11):3229-3239. doi:10.1002/eji.200737249.
Klawiter E, Piccio L, Lyons J, Mikesell R, O’Connor K, Cross A. Elevated intrathecal myelin oligodendrocyte glycoprotein antibodies in multiple sclerosis. Arch Neurol. 2010;67(9). doi:10.1001/archneurol.2010.197.
Tomassini V, De Giglio L, Reindl M et al. Anti-myelin antibodies predict the clinical outcome after a first episode suggestive of MS. Multiple Sclerosis. 2007;13(9):1086-1094. doi:10.1177/1352458507077622.
Kuhle J, Pohl C, Mehling M et al. Lack of association between antimyelin antibodies and progression to multiple sclerosis. New England Journal of Medicine. 2007;356(4):371-378. doi:10.1056/nejmoa063602.
Levin CM. Autoantibodies to non-myelin antigens as contributors to the pathogenesis of multiple sclerosis. J Clin Cell Immunol. 2013;04(03). doi:10.4172/2155-9899.1000148.
Ousman S, Tomooka B, Van Noort J et al. Protective and therapeutic role for α b-crystallin in autoimmune demyelination. Clinical Immunology. 2007;123:139. doi:10.1016/j.clim.2007.03.034.
Owens G, Gilden D, Burgoon M, Yu X, Bennett J. Viruses and multiple sclerosis. The Neuroscientist. 2011;17(6):659-676. doi:10.1177/1073858411386615.
Farrell R, Antony D, Wall G et al. Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI. Neurology. 2009;73(1):32-38. doi:10.1212/wnl.0b013e3181aa29fe.
Füst G. The role of the Epstein—Barr virus in the pathogenesis of some autoimmune disorders — similarities and differences. European Journal of Microbiology and Immunology. 2011;1(4):267-278. doi:10.1556/eujmi.1.2011.4.2.
Sundstrom P, Juto P, Wadell G et al. An altered immune response to Epstein—Barr virus in multiple sclerosis: A prospective study. Neurology. 2004;62(12):2277-2282. doi:10.1212/01.wnl.0000130496.51156.d7.
Levin L. Temporal relationship between elevation of Epstein—Barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis. JAMA. 2005;293(20):2496. doi:10.1001/jama.293.20.2496.
DeLorenze G, Munger K, Lennette E, Orentreich N, Vogelman J, Ascherio A. Epstein—Barr virus and multiple sclerosis. Arch Neurol. 2006;63(6):839. doi:10.1001/archneur.63.6.noc50328.
Thacker E, Mirzaei F, Ascherio A. Infectious mononucleosis and risk for multiple sclerosis: A meta-analysis. Annals of Neurology. 2006;59(3):499-503. doi:10.1002/ana.20820.
Nielsen T, Rostgaard K, Nielsen N et al. Multiple sclerosis after infectious mononucleosis. Arch Neurol. 2007;64(1):72. doi:10.1001/archneur.64.1.72.
Esposito M et al. Human transaldolase and crossreactive viral epitopes identified by autoantibodies of multiple sclerosis patients. J Immunol. 1999;163(7):4027-4032.
Lunemann J, Kamradt T, Martin R, Munz C. Epstein—Barr virus: environmental trigger of multiple sclerosis? Journal of Virology. 2007;81(13):6777-6784. doi:10.1128/jvi.00153-07.
Lang H, Jacobsen H, Ikemizu S et al. A functional and structural basis for TCR cross-reactivity in multiple sclerosis. Nature Immunology. 2002;3(10):940-943. doi:10.1038/ni835.
Meier U, Giovannoni G, Tzartos J, Khan G. Translational Mini-Review Series on B cell subsets in disease. B cells in multiple sclerosis: drivers of disease pathogenesis and Trojan horse for Epstein—Barr virus entry to the central nervous system? Clinical & Experimental Immunology. 2011;167(1):1-6. doi:10.1111/j.1365-2249.2011.04446.x.
Reiber H, Ungefehr S, Jacobi C. The intrathecal, polyspecific and oligoclonal immune response in multiple sclerosis. Multiple Sclerosis. 1998;4(3):111-117. doi:10.1177/135245859800400304.
Felgenhauer K, Reiber H. The diagnostic significance of antibody specificity indices in multiple sclerosis and herpes virus induced diseases of the nervous system. Clin Investig. 1992;70(1):28-37. doi:10.1007/bf00422934.
Sindic C, Monteyne P, Laterre E. The intrathecal synthesis of virus-specific oligoclonal IgG in multiple sclerosis. Journal of Neuroimmunology. 1994;54(1-2):75-80. doi:10.1016/0165-5728(94)90233-x.
Frederiksen J, Sindic C. Intrathecal synthesis of virus-specific oligoclonal IgG, and of free kappa and free lambda oligoclonal bands in acute monosymptomatic optic neuritis. Comparison with brain MRI. Multiple Sclerosis. 1998;4(1):22-26. doi:10.1191/135245898678909213.
Jarius S, Eichhorn P, Jacobi C, Wildemann B, Wick M, Voltz R. The intrathecal, polyspecific antiviral immune response: Specific for MS or a general marker of CNS autoimmunity? Journal of the Neurological Sciences. 2009;280(1-2):98-100. doi:10.1016/j.jns.2008.08.002.
Jarius S, Franciotta D, Bergamaschi R et al. Polyspecific, antiviral immune response distinguishes multiple sclerosis and neuromyelitis optica. Journal of Neurology, Neurosurgery & Psychiatry. 2008;79(10):1134-1136. doi:10.1136/jnnp.2007.133330.
Robinson-Agramonte M, Reiber H, Cabrera-Gomez J, Galvizu R. Intrathecal polyspecific immune response to neurotropic viruses in multiple sclerosis: a comparative report from Cuban patients. Acta Neurologica Scandinavica. 2007;115(5):312-318. doi:10.1111/j.1600-0404.2006.00755.x.
Brecht I, Weissbrich B, Braun J, Toyka K, Weishaupt A, Buttmann M. Intrathecal, polyspecific antiviral immune response in oligoclonal band negative multiple sclerosis. PLoS ONE. 2012; 7(7):e40431. doi:10.1371/journal.pone.0040431.
Bonnan M. Does disease-irrelevant intrathecal synthesis in multiple sclerosis make sense in the light of tertiary lymphoid organs? Frontiers in Neurology. 2014;5. doi:10.3389/fneur.2014.00027.
Villar L, Sádaba M, Roldán E et al. Intrathecal synthesis of oligoclonal IgM against myelin lipids predicts an aggressive disease course in MS. Journal of Clinical Investigation. 2005;115(1):187-194. doi:10.1172/jci200522833.
Kabat E, Moore D, Landow H. An electrophoretic study of the protein components in cerebrospinal fluid and their relationship to the serum proteins. Journal of Clinical Investigation. 1942; 21(5):571-577. doi:10.1172/jci101335.
Frick E, Scheid-Seydel L. Untersuchungen mit J131-markiertem Globulin zur Frage der Abstammung der Liquoreiweissk. Klin Wochenschr. 1958;36(18):857-863. doi:10.1007/bf01485232.
Laterre EC. Agar gel electrophoresis of cerebrospinalfluid proteins. Semiology of the γ-zone. Acta Neurol Psychiatr Belg. 1966;66:289-304.
Keir G, Luxton R, Thompson E. Isoelectric focusing of cerebrospinal fluid immunoglobulin G: An annotated update. Annals of Clinical Biochemistry: An international journal of biochemistry and laboratory medicine. 1990;27(5):436-443. doi:10.1177/000456329002700504.
Holmoy T. The discovery of oligoclonal bands: a 50-year anniversary. European Neurology. 2009;62(5):311-315. doi:10.1159/000235944.
Bourahoui A, de Seze J, Guttierez R et al. CSF isoelectrofocusing in a large cohort of MS and other neurological diseases. Eur J Neurol. 2004;11(8):525-529. doi:10.1111/j.1468-1331.2004.00822.x.
Polman C, Reingold S, Edan G et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the «McDonald Criteria». Annals of Neurology. 2005;58(6):840-846. doi:10.1002/ana.20703.
Polman C, Reingold S, Banwell B et al. Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria. Annals of Neurology. 2011;69(2):292-302. doi:10.1002/ana.22366.
Tintore M, Rovira A, Rio J et al. Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis? Neurology. 2007;70:13:2:1079-1083. doi:10.1212/01.wnl.0000280576.73609.c6.
Rojas J, Patrucco L, Cristiano E. Erratum to: Oligoclonal bands and MRI in clinically isolated syndromes: predicting conversion time to multiple sclerosis. Journal of Neurology. 2010;257(7):1231-1231. doi:10.1007/s00415-010-5561-0.
Joseph F, Hirst C, Pickersgill T, Ben-Shlomo Y, Robertson N, Scolding N. CSF oligoclonal band status informs prognosis in multiple sclerosis: a case control study of 100 patients. Journal of Neurology, Neurosurgery & Psychiatry. 2009;80(3):292-296. doi:10.1136/jnnp.2008.150896.
von Glehn F, Farias A, de Oliveira A et al. Disappearance of cerebrospinal fluid oligoclonal bands after natalizumab treatment of multiple sclerosis patients. Multiple Sclerosis Journal. 2011;18(7):1038-1041. doi:10.1177/1352458511428465.
Stark J, Koffler D, Sadiq S. Persistence of Cerebrospinal Fluid Oligoclonal Bands after Natalizumab Treatment in Multiple Sclerosis Patients. Neurology. 2013;80:1:05.187.
Mancardi G, Saccardi R. Autologous haematopoietic stem-cell transplantation in multiple sclerosis. The Lancet Neurology. 2008;7(7):626-636. doi:10.1016/s1474-4422(08)70138-8.
Rogojan C, Frederiksen J. Hematopoietic stem cell transplantation in multiple sclerosis. Acta Neurologica Scandinavica. 2009;120(6):371-382. doi:10.1111/j.1600-0404.2009.01168.x.
Brettschneider J, Tumani H, Kiechle U et al. IgG Antibodies against Measles, Rubella, and Varicella Zoster Virus Predict Conversion to Multiple Sclerosis in Clinically Isolated Syndrome. PLoS ONE. 2009;4(11):7638. doi:10.1371/journal.pone.0007638.
Brecht I, Weissbrich B, Braun J, Toyka K, Weishaupt A, Buttmann M. Intrathecal, polyspecific antiviral immune response in oligoclonal band negative multiple sclerosis. PLoS ONE. 2012;7(7):40431. doi:10.1371/journal.pone.0040431.
Rosche B, Laurent S, Conradi S, Hofmann J, Ruprecht K, Harms L. Measles IgG antibody index correlates with T2 lesion load on MRI in patients with early multiple sclerosis. PLoS ONE. 2012;7(1):28094. doi:10.1371/journal.pone.0028094.
Villar L, Masjuan J, Gonzalez-Porque P et al. Intrathecal IgM synthesis predicts the onset of new relapses and a worse disease course in MS. Neurology. 2002;59(4):555-559. doi:10.1212/wnl.59.4.555.